Literature DB >> 10643514

Squamous cell carcinoma of the penis.

G Schoeneich1, F G Perabo, S C Müller.   

Abstract

Squamous cell carcinoma of the penis is a rare disease in Western countries. In geographical locations where infantile circumcision is not routinely practised and genital hygiene is poor, penile cancer may comprise 10-20% of all malignancies. Superficial tumours (Ta-Tl) should be treated with organ-preserving therapy. Partial of total penectomy is recommended for invasive penile carcinoma (stage T2 or higher). Currently, management of the ilioinguinal lymph nodes is controversial. The value of radiation therapy and chemotherapy is still uncertain; these treatments are only palliative therapy modalities.

Entities:  

Mesh:

Year:  1999        PMID: 10643514     DOI: 10.1111/j.1439-0272.1999.tb01445.x

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  5 in total

Review 1.  [Systemic therapy of penile cancer].

Authors:  E Preis; P Albers; G Jakse
Journal:  Urologe A       Date:  2006-05       Impact factor: 0.639

Review 2.  [Options in palliative therapy for penile cancer].

Authors:  E Preis; G Jakse
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

Review 3.  Current trends in the management of carcinoma penis--a review.

Authors:  Iqbal Singh; A Khaitan
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

4.  Predictive pathological factors of lymph nodes involvement in the squamous cell carcinoma of the penis.

Authors:  Vincenzo Ficarra; Guido Martignoni; Nicola Maffei; Maria Angela Cerruto; Giacomo Novara; Stefano Cavalleri; Walter Artibani
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 5.  HPV Carcinomas in Immunocompromised Patients.

Authors:  Nicole M Reusser; Christopher Downing; Jacqueline Guidry; Stephen K Tyring
Journal:  J Clin Med       Date:  2015-01-29       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.